{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:56:49Z","timestamp":1790787409753,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pulmonary hypertension (PH) is increasingly recognized as a systemic vascular disorder with extrapulmonary end-organ involvement. Within oculomics, ocular imaging biomarkers are explored as systemic disease surrogates reflecting microvascular pathology. Owing to its high flow, fenestrated vasculature, and venous drainage pattern, the choroid is particularly susceptible to venous congestion and impaired ocular perfusion pressure. Optical coherence tomography (OCT) and OCT angiography (OCT-A) enable non-invasive quantitative assessment of choroidal structure, vascularity, and perfusion, thereby giving rise to candidate oculomic readouts\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative review of PubMed, Web of Science, and Scopus (through December 2025) identified clinical OCT\/OCT-A studies and case reports on choroidal parameters in PH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Due to concurrent, competing hemodynamic forces, two ends of a dynamic continuum of the choroidal end-organ phenotypes were identified. PH-targeted therapies and autonomic dysregulation may further modify this spectrum. A congestive pachychoroid-like phenotype, demonstrated in idiopathic pulmonary arterial hypertension, is characterized by pressure-dependent choroidal venous congestion, increased subfoveal choroidal thickness, and serous retinal detachment. An ischemic phenotype is characterized by choroidal thinning, perfusion defects, and structural remodeling. In chronic thromboembolic PH, OCT-A shows ischemic signatures with reduced vessel density and an enlarged foveal avascular zone. In precapillary PH, a prospective OCT study reveals reduced choroidal thickness and volume without consistent association with invasive cardiopulmonary hemodynamics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Choroidal oculomic candidate markers reflect microvascular remodeling in PH. Currently they lack sufficient validation as standalone surrogates of cardiopulmonary disease severity. Longitudinal multimodal imaging integrated with invasive hemodynamics is required to define their translational clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1779239","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:50:28Z","timestamp":1773903028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The choroid as a vascular sensor in pulmonary hypertension: an oculomic mini review"],"prefix":"10.3389","volume":"13","author":[{"given":"Diana A.","family":"Dmuchowska","sequence":"first","affiliation":[{"name":"Ophthalmology Department, Medical University of Bialystok","place":["Bialystok, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3238\/arztebl.2017.0073","article-title":"Pulmonary hypertension","volume":"114","author":"Hoeper","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/bmj.j5492","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"122","author":"Thenappan","year":"2018","journal-title":"Circ Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"D4","DOI":"10.1016\/j.jacc.2013.10.025","article-title":"Relevant issues in the pathology and pathobiology of pulmonary hypertension","volume":"62","author":"Tuder","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/eye.1990.39","article-title":"In vivo choroidal circulation and its watershed zones","volume":"4","author":"Hayreh","year":"1990","journal-title":"Eye (Lond)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.survophthal.2019.02.009","article-title":"Ocular manifestations of pulmonary hypertension","volume":"64","author":"Lewczuk","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/IJG.0000000000001090","article-title":"Choroidal detachment and increased intraocular pressure in a case of secondary pulmonary hypertension","volume":"28","author":"Lei","year":"2019","journal-title":"J Glaucoma"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1097\/IAE.0000000000000457","article-title":"Diagnostic and therapeutic challenges","volume":"35","author":"Dmuchowska","year":"2015","journal-title":"Retina"},{"key":"B12","doi-asserted-by":"publisher","first-page":"31693","DOI":"10.1038\/s41598-025-17425-z","article-title":"Linking cardiological parameters and choroidal changes in patients with precapillary pulmonary hypertension: a cross-sectional study","volume":"15","author":"Zonenberg","year":"2025","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00006982-200102000-00006","article-title":"Familial primary pulmonary hypertension and associated ocular findings","volume":"21","author":"Saran","year":"2001","journal-title":"Retina"},{"key":"B14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0002-9394(02)02090-1","article-title":"Uveal effusion and angle-closure glaucoma in primary pulmonary hypertension","volume":"135","author":"Krohn","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/ICB.0000000000000336","article-title":"Acute serous retinal detachment in idiopathic pulmonary arterial hypertension","volume":"11","author":"Martiano","year":"2017","journal-title":"Retin Cases Brief Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00417-016-3352-8","article-title":"Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension","volume":"254","author":"Matieli","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1136\/bmj.e554","article-title":"Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension","volume":"344","author":"Wirostko","year":"2012","journal-title":"Br Med J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/IAE.0000000000002940","article-title":"Optical coherence tomography angiography findings of microvascular and neural changes in primary pulmonary hypertension","volume":"41","author":"Gu","year":"2021","journal-title":"Retina"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1097\/IAE.0000000000003607","article-title":"Optical coherence tomography angiography findings in patients with chronic thromboembolic pulmonary hypertension","volume":"42","author":"Krajewski","year":"2022","journal-title":"Retina"},{"key":"B20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/17476348.2024.2361037","article-title":"Extrapulmonary manifestations of pulmonary arterial hypertension","volume":"18","author":"Singh","year":"2024","journal-title":"Expert Rev Respir Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s40123-020-00286-2","article-title":"Guidelines on optical coherence tomography angiography imaging: 2020 focused update","volume":"9","author":"Borrelli","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.preteyeres.2020.100829","article-title":"Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index","volume":"77","author":"Agrawal","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41433-024-03253-4","article-title":"Pachychoroid disease: review and update","volume":"39","author":"Cheung","year":"2025","journal-title":"Eye"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00417-023-06342-4","article-title":"Macular choroidal thickness, volume, and vascularity index in patients with systemic sclerosis","volume":"262","author":"Pieklarz","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1273438","DOI":"10.3389\/fmed.2023.1273438","article-title":"Peripapillary choroidal vascularity index and thickness in patients with systemic sclerosis","volume":"10","author":"Pieklarz","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/biology10080725","article-title":"Quantitative assessment of choroidal parameters in patients with Various types of diabetic macular oedema: a single-centre cross-sectional analysis","volume":"10","author":"Dmuchowska","year":"2021","journal-title":"Biology (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/IAE.0b013e3181eef0ae","article-title":"The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography","volume":"31","author":"Vance","year":"2011","journal-title":"Retina"},{"key":"B28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1755-3768.2011.02305.x","article-title":"Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra\u00ae)","volume":"91","author":"Kim","year":"2013","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1023\/A:1014410932321","article-title":"Sildenafil increases ocular perfusion","volume":"23","author":"Paris","year":"2001","journal-title":"Int Ophthalmol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7174540","DOI":"10.1155\/2017\/7174540","article-title":"Changes in retinal and choroidal vascular blood flow after oral sildenafil: an optical coherence tomography angiography study","volume":"2017","author":"Berrones","year":"2017","journal-title":"J Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1006\/exer.2000.0911","article-title":"Endothelin modulation of choroidal blood flow in the rabbit","volume":"71","author":"Kiel","year":"2000","journal-title":"Exp Eye Res"},{"key":"B32","first-page":"864","article-title":"Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina","volume":"41","author":"Dallinger","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1167\/iovs.02-0372","article-title":"Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans","volume":"44","author":"Fuchsj\u00e4ger-Mayrl","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s40123-025-01238-4","article-title":"Retinal and choroidal alterations in heart failure: a systematic review and meta-analysis of OCT and OCT-A findings with emphasis on HFrEF","volume":"14","author":"Bayat","year":"2025","journal-title":"Ophthalmol Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/02713683.2025.2523913","article-title":"The effects of tadalafil on optical coherence tomography, optical coherence tomography angiography and ganglion cell complex parameters in patients with erectile dysfunction","volume":"50","author":"Feizi","year":"2025","journal-title":"Curr Eye Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1167\/iovs.03-0177","article-title":"Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects","volume":"44","author":"Polak","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1183\/09031936.00039808","article-title":"First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension","volume":"33","author":"Grimminger","year":"2009","journal-title":"Eur Respir J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"101350","DOI":"10.1016\/j.preteyeres.2025.101350","article-title":"Oculomics: current concepts and evidence","volume":"106","author":"Zhu","year":"2025","journal-title":"Prog Retinal Eye Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/jcm9020595","article-title":"Choroidal vascularity Index: an in-depth analysis of this novel optical coherence tomography parameter","volume":"9","author":"Iovino","year":"2020","journal-title":"J Clin Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"101292","DOI":"10.1016\/j.preteyeres.2024.101292","article-title":"Optical coherence tomography angiography of the retina and choroid in systemic diseases","volume":"103","author":"Chua","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000067549","article-title":"Effects of sildenafil citrate (viagra) on choroidal congestion","volume":"216","author":"McCulley","year":"2002","journal-title":"Ophthalmologica"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1779239\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:50:29Z","timestamp":1773903029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1779239\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":41,"alternative-id":["10.3389\/fcvm.2026.1779239"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1779239","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"1779239"}}